CEO & Founder
EN Rx, Inc.
Erik R. Piatt is the CEO and founder of EN Rx, Inc. where he has also served as director of Technology Development for 15 years. Under the direction of Piatt, EN Rx has developed multiple products for the environmental industry. ENRx's first product system, SynergistTM,, involves the application of concentrated hydrogen peroxide above ground, with no negative exothermic or precipitation impacts. Another product, FOCISTM, is a method of treating sites chemically with a mixing device that is mounted on reagent tanks. More recently, the company has deployed VertebraeTM, a multiuse horizontal well system capable of providing a unique approach to site assessment and remediation. Erik is a service-disabled veteran having served in Desert Storm as a Sergeant in the U.S. Marine Corps.
FLASH POSTER PRESENTATION
Segmented Horizontal Well Systems for Targeted Remediation with ISCO
The deployment of horizontal wells for site assessment and remediation has experienced a revival due to decreased cost and greater flexibility in deployment. The latter is specifically tied to moving from monolithic single well systems, that are subject to preferential path distortions, to segmented well systems. The resultant discretized horizontal profiling brings additional accuracy to assessment at sites, especially those challenged by access issues and also provides more directed treatment operations. Conceptual Site Modela (CSMs) can be significantly enhanced with new perspectives and, on a case by case basis, there can be significant economic advantages. Several case studies will be presented that illuminate the advantages of segmented horizontal well systems, that also incorporate miniaturization and nested bundling methods into the process. The improved flexibility and the integrity of the data sets that are collected and the ability to deliver reagents with improved precision will be illustrated.